Pancreatic Disorders News

Patients with pancreatic cancer who had tumors with a combination of the highest neoantigen number and the most abundant CD8-positive T-cell infiltrates survived significantly longer than those without those tumor characteristics, according to study results.

A new clinical guideline from the American Gastroenterological Association provides up-to-date recommendations for early treatment decisions in acute pancreatitis.

Stand Up To Cancer, in collaboration with the Lustgarten Foundation for Pancreatic Cancer Research, is supporting a new translational research team that will explore how chimeric antigen receptor T-cell therapy can be applied to pancreatic cancer.

The FDA granted orphan drug designation to BPM31510 for the treatment of pancreatic cancer, according to the agent’s manufacturer.

Researchers at University of Washington have developed a smartphone app designed to detect jaundice, a common early symptom of pancreatic cancer.

A novel blood assay successfully identified tumor-specific DNA and protein biomarkers in a cohort of patients with early-stage pancreatic cancer.

A genetic polymorphism was a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease, according to a study published in Alimentary Pharmacology & Therapeutics.

Investigators found no evidence that regular use of aspirin or NSAIDs increases the risk for pancreatic cancer in a recent study.

The National Cancer Institute’s Pancreatic Cancer Detection Consortium has awarded a $5.13 million grant to researchers from Baylor Scott & White Research Institute and the Translational Genomics Research Institute, which are developing a blood test for early detection of pancreatic cancer.

Endoscopists and centers that performed a high volume of endoscopic retrograde cholangiopancreatography procedures showed higher rates of overall procedural success and lower rates of adverse events in a recent study.